This article showcases our top picks for the best Surrey based Biotechnology companies. These startups and companies are taking a variety of approaches to innovating the Biotechnology industry, but are all exceptional companies well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups and companies for exceptional performance in one of these categories:
- Innovative ideas
- Innovative route to market
- Innovative product
- Exceptional growth
- Exceptional growth strategy
- Societal impact
Top Surrey Biotechnology Companies
ReNeuron Group Plc engages in the research, development, and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. It develops stem cell therapies for a range of neurodegenerative diseases and other conditions, including Parkinson’s disease, Type 1 diabetes, and diseases of the retina.
The company’s therapeutic product pipeline includes ReN001, a pre-clinical development stage therapy for disabled stroke patients. Its other therapeutic and non-therapeutic programs in pre-clinical trials comprise ReN002 for diabetes, ReN003 for retinal diseases, ReN004 for Parkinson’s disease, and ReN005 for Huntington’s disease.
ReNeuron Group also develops and markets neural stem cell lines that include ReNcell VM and ReNcell CX. The company was founded in 1997 and is headquartered in Guildford, the United Kingdom..
ANGLE is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. It also owns a successful specialist technology consultancy and a major investment in a business with a unique computer graphics technology platform.
The business has matured so that it now focuses on its established 90%+ owned businesses with unique high-value patent-protected medical technologies addressing multi-billion dollar markets. ANGLE’s lead product is the Parsortix cell separation device, which can capture very rare circulating tumor cells (CTCs) in cancer patient blood – even when there is less than one CTC in one billion healthy cells.
ANGLE has launched a product for the research market and is aiming to secure CE Mark regulatory approval for the clinical market in 2013 with FDA approval in 2014. ANGLE has a highly efficient investment model.
Costs are minimized by the use of third party collaborations and partnerships and by the contribution of its consulting business to overheads. The existing businesses are over six years old.
ANGLE’s efforts are directed to maximizing shareholder returns from these businesses and there are no plans to set up new companies. Risk is further offset by the revenue-generating computer graphics company, which has the potential to deliver a near-term capital return to ANGLE.
ANGLE was founded by Andrew Newland in 1994 to bridge a gap between research and the market. ANGLE’s business model is to set up, own and operate technology companies to commercialise world-class research..
NatureMetrics is an award-winning technology start-up using cutting-edge genetic techniques to monitor biodiversity. Each species carries a unique genetic signature in all cells.
When an organism’s cells are shed into the environment (e.g. through excretion, mucous, saliva, gametes, or tissue breakdown) its genetic signature is also released.
At NatureMetrics, we isolate these signatures from water or sediment samples – or from complex mixed-species samples of invertebrates – and use them to determine which species are present.. .
ReBio Technologies is an industrial biotechnology company that specializes in the developing proprietary routes to key commodity platform biochemicals from renewable resources. It also develops tools in biotechnology to elucidate and design new biosynthetic pathways in a range of microbial hosts, for the efficient and cost-effective production of high-value chemicals through fermentation.
This, coupled with state-of-the-art polymer technology, provides manufacturing industries with innovative solutions to their raw material requirements. It was founded in 2014 and is headquartered in Cranleigh, Surrey, United Kingdom..
Shield Therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. During 2011 Shield will be commencing global pivotal Phase III studies of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with inflammatory bowel disease and subsequently chronic kidney disease.
The Company is headquartered in Wollerau, Switzerland.. .
Around the world, patients with unmet medical needs are frequently driven to seek access to medicines outside the clinical trial and commercial setting. Idis is the leading expert in developing, implementing and managing global Managed Access Programs by which pharmaceutical and biotechnology companies and healthcare providers can respond to the needs of these patients.
Idis has over 27 years experience of partnering with pharmaceutical and biotechnology companies to create regulatory-compliant, ethical access to medicines for healthcare professionals and their patients with unmet medical needs. Since 1987, Idis has developed and managed access to thousands of medicines from virtually every therapeutic category, impacting the lives of hundreds of thousands of patients.
Around the world, a variety of terms are used to describe these programs including “expanded access”, “named patient”, “ATU”, “compassionate use”, and “early access”.. .
Texture Technologies Corp
The leader in texture analysis and texture measurement instruments for university research and product testing. From meeting compliance requirements in the pharmaceutical and cosmetics industries to achieving quality standards in foods and medical devices, clients trust Texture Technologies to provide them with product testing solutions that make their job easier and deliver reliable texture analysis.
Fortune 500 companies and major universities rely on Texture Technologies to help them choose testing equipment that accurately and cost-effectively meets all of their texture analysis needs. Their comprehensive line of materials testing solutions measures the composition, performance and market viability of thousands of adhesives, films, gels, and powders as well as building materials and electronics products..
Microgen Bioproducts is an evolving international company recognised by its customers as a global leader in the development, manufacture, distribution, and marketing of products in its associated industries. The portfolio encompasses products used within clinical laboratories including a comprehensive list of diagnostic products for microbiology, serology, haematology and virology.
The company also has a long history of providing solutions to the food testing industry. At Microgen, we constantly strive to improve and deliver high quality products as a consequence of our commitment and investment in Science.
We pride ourselves on the strong relationships we have developed with our loyal customer base, and constantly challenge ourselves to reward this loyalty with an expanding offering of practical, cost-effective, innovative, and easy-to-use assays, with the high performance characteristics we have come to expect of ourselves.. .
C-Cure Solutions Limited
C-Cure Solutions Limited offers a unique combination of contaminated land and ecology expertise. Our proprietary products are produced from renewable sources and provide a low carbon solution to contaminated land remediation that: de-toxifies metal contaminated soils and spoils by immobilising heavy metal ions in a non-bio-available and non-leachable form.
restores soil fertility promotes indigenous natural vegetation growth thus preventing contamination of the wider environment via wind-blown dust and erosion allows application in environmentally sensitive environments Increasing demands to protect the environment and human health is driving new regulations. Our products and services provide an effective and sustainable solution to meet these increasing demands.
The production and application of our technology sequesters carbon, provides renewable energy, removes environmental liability in the immediate and long term and informs the sustainable management of forest and agricultural land.. .
Pathway Diagnostics Ltd is a leading supplier of specialist clinical and research diagnostics in the UK. The Company is based in Dorking, Surrey and was established in 1998 to provide quality in-vitro diagnostic products and instrumentation to clinical, research and industrial laboratories mainly in the UK and Ireland.
The Company is highly focused on the needs of its customers and in providing the highest quality products and service. It has developed a number of partnerships with Diagnostics manufacturers in order to supply its customers with complete and innovative diagnostic solutions.
Pathway Diagnostics also manufacturers its own range of haemostasis tests and allergy controls that are marketed internationally, together with those of Unicorn Diagnostics Ltd through local distributors or direct from the UK. The Company also operates its independent PathQAS Quality Assurance schemes as a service to customers..
Academic Concept Knowledge
Semantically analyse scientific text, e.g. journal articles, and link terms of scientific significance to scientific products and other relevant scientific information.
The semantic analysis can be done at source (XML/HTML), via browsers (HTML Bookmarklet) and in PDFs (via the scientific PDF reader Utopia Documents – UD). Links to products are either displayed alongside the scientific text (at source or in UD), or presented in a new tab or window (browser bookmarklet).
In UD and the browser bookmarklet also links to relevant non-commercial scientific information is given, in order to make the software (UD and bookmarklet) attractive for scientists to use, and to put the ‘infotising’ of scientific products in a scientific information context (as opposed to the purely commercial context of e.g. banner advertisements).
The results of semantic analyses of scientific content are also offered to suppliers of scientific products. Currently the focus is on the life and medical sciences spectrum, but the underlying software – though not the semantic thesauri used, which differ per discipline – is generic in nature..
You may write to us at: BestStartup.co.uk/Fupping Ltd, 349 Royal College Street, London, England, NW1 9QS.